BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38148258)

  • 21. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinically Node Negative, Pathologically Node Positive Rectal Cancer Patients Who Did Not Receive Neoadjuvant Therapy.
    Akeel N; Lan N; Stocchi L; Costedio MM; Dietz DW; Gorgun E; Kalady MF; Karagkounis G; Kessler H; Remzi FH
    J Gastrointest Surg; 2017 Jan; 21(1):49-55. PubMed ID: 27796635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
    Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
    BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].
    Sauer J; Sobolewski K; Dommisch K
    Zentralbl Chir; 2009 Sep; 134(5):450-4. PubMed ID: 19757345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation of Tumor Response Between Flexible Sigmoidoscopy and Magnetic Resonance Imaging in Patients Undergoing Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Retrospective Review.
    Rojas MA; Cataneo J; Gagnon-Konamna M; Borsuk DJ; Jarzabek AJ; Marecik SJ; Park JJ; Kochar K
    Am Surg; 2023 Jun; 89(6):2595-2599. PubMed ID: 35617529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.
    Bilimoria KY; Bentrem DJ; Stewart AK; Winchester DP; Ko CY
    J Clin Oncol; 2009 Sep; 27(25):4177-81. PubMed ID: 19636004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total Neoadjuvant Treatment for Rectal Cancer: Preliminary Experience.
    Gilshtein H; Ghuman A; Dawoud M; Yellinek S; Kent I; Sharp SP; Nagarajan A; Wexner SD
    Am Surg; 2021 May; 87(5):708-713. PubMed ID: 33169626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is local excision an appropriate treatment modality in patients presenting with early-stage (cT1 N0 M0) rectal adenocarcinoma?
    Roat-Shumway S; Tonelli C; Singer M; Cohn T; Luchette FA; Abdelsattar Z; Baker MS
    Surgery; 2023 Mar; 173(3):665-673. PubMed ID: 36273975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
    Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project.
    Pellino G; Alós R; Biondo S; Codina-Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; Cervantes A; García-Granero E;
    Eur J Surg Oncol; 2021 Feb; 47(2):276-284. PubMed ID: 32950316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare Data.
    Charlton ME; Hrabe JE; Wright KB; Schlichting JA; McDowell BD; Halfdanarson TR; Lin C; Stitzenberg KB; Cromwell JW
    J Gastrointest Surg; 2016 May; 20(5):1002-11. PubMed ID: 26658793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between cancer center accreditation and performance on publicly reported quality measures.
    Merkow RP; Chung JW; Paruch JL; Bentrem DJ; Bilimoria KY
    Ann Surg; 2014 Jun; 259(6):1091-7. PubMed ID: 24509202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Current Status of Rectal Cancer Care in the US: Where We Stand at the Start of the Commission on Cancer's National Accreditation Program for Rectal Cancer.
    Brady JT; Xu Z; Scarberry KB; Saad A; Fleming FJ; Remzi FH; Wexner SD; Winchester DP; Monson JRT; Lee L; Dietz DW;
    J Am Coll Surg; 2018 May; 226(5):881-890. PubMed ID: 29580675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal cancer and teaching hospitals: hospital teaching status affects use of neoadjuvant radiation and survival for rectal cancer patients.
    Stewart DB; Hollenbeak C; Desharnais S; Camacho F; Gladowski P; Goff VL; Wang L
    Ann Surg Oncol; 2013 Apr; 20(4):1156-63. PubMed ID: 23184292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
    de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
    Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers.
    Miller ME; Bleicher RJ; Kaufman CS; Kurtzman SH; Chang C; Wang CH; Pollitt KA; Connolly J; Winchester DP; Yao KA
    Ann Surg Oncol; 2019 May; 26(5):1202-1211. PubMed ID: 30684159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.